Literature DB >> 30942387

The epidemiology and management of clusters of invasive meningococcal disease in England, 2010-15.

Maya Gobin1, Gareth Hughes2, Sarah Foulkes3, Helen Bagnall3, Amy Trindall4, Valérie Decraene5, Obaghe Edeghere3, Sooria Balasegaram6, Amelia Cummins7, Louise Coole2.   

Abstract

BACKGROUND: Guidance for public health management of invasive meningococcal disease (IMD) in in England recommends the use of antibiotic chemoprophylaxis and vaccination. We summarized clinical and epidemiological data collected during routine management of IMD clusters in England.
METHODS: Data on epidemiology and operational decisions for public health management were reviewed for clusters between April 2010 and December 2015.
RESULTS: Clusters were generally 2-3 cases (53/58; 91%) within a single age band <18-years. Nurseries (n = 20, 34%), households/social networks (n = 14, 24%) and schools (n = 10, 17%) were the commonest settings. Chemoprophylaxis alone was used in 36 (58%) clusters, including most serogroup B clusters (31/41; 76%). Chemoprophylaxis and vaccination was used in a further 20 (32%) clusters. Vaccine was delivered promptly (<7 days). Four clusters had cases with onset post-chemoprophylaxis; no clusters recorded cases with onset post-vaccination. No pattern was observed between interventions and setting/population at risk, and interventions were consistent with national guidance. Challenges to management included logistical issues related to intervention delivery.
CONCLUSIONS: Public health management of IMD clusters presents challenges in decision-making and implementation of interventions. Nonetheless, few cases were observed following intervention. Responses were consistent with national guidance. A systematic data collection tool should be developed to support future evaluation. © Crown copyright 2019.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30942387     DOI: 10.1093/pubmed/fdz028

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  2 in total

1.  Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B in a nursery school, Wallonia, Belgium, 2018.

Authors:  Stéphanie Jacquinet; Wesley Mattheus; Sophie Quoilin; Chloé Wyndham-Thomas; Charlotte Martin; Dimitri Van der Linden; André Mulder; Julie Frère; Carole Schirvel
Journal:  Euro Surveill       Date:  2022-03

2.  Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis.

Authors:  Sandra Guedes; Hélène Bricout; Edith Langevin; Sabine Tong; Isabelle Bertrand-Gerentes
Journal:  BMC Public Health       Date:  2022-03-17       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.